Funding event
The round itself, as filedAmount soldOffering filed, nothing sold yet · $30.0M offered
Filed2026-10-22
Days since filing22
- Exemption claimed
- Rule 506(b)
- First-ever Form D
- No
Investors
No investors named: Form D does not list them
Officers on the filing
Names and roles as filed; addresses are never stored- Todd FlohrExecutive Officer · Director
- Keith RosmarinExecutive Officer
- Jon WallaceExecutive Officer · Director
- William BuchananDirector
- Ryan MajoriaDirector
- Ronald SanchoDirector
- C. William MartinDirector
- Richard MooreDirector
Health flags
Three flags, each with the raw inputs behind it · as of 2026-11-13UndersubscribedNot flaggedOffering filed, nothing sold yetNo date of first sale on the filing
Prior raiseNot flagged$139K prior raiseprior filing 2026-02-09
AmendedNot flaggedD/A on 2026-08-05Amount offered unchanged or not stated
Open roles
On the employer's own careers page · checked 2026-10-240
Pre-posting windowNot enough dataShown once this sector and stage have 20 observed lags from filing to first posting.
No open roles foundWe read careers pages daily.
All filings
Every filing for this company, newest first, amendments includedAlso raised in Health & bio
Same sector, 28 days to 2026-11-15OrcosaSeries A · $6.0M of $11.5M · Ewing, NJQuietChronicleBioPre-seed · $250K of $1.0M · Menlo Park, CAQuiet
103 rounds in Health & bio in the 28 days to 2026-11-12, against 122 in the 28 days before.